NCT00085345 · Interventional trial
Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
Overall registry status Withdrawn
Phase 2
Conditions Refractory Plasma Cell Neoplasm, Stage II Multiple Myeloma, Stage III Multiple Myeloma
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory